Private Advisor Group LLC boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 2.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,382 shares of the company’s stock after purchasing an additional 84 shares during the quarter. Private Advisor Group LLC’s holdings in HCA Healthcare were worth $1,374,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. CreativeOne Wealth LLC acquired a new position in HCA Healthcare in the 1st quarter worth approximately $231,000. Bessemer Group Inc. increased its holdings in shares of HCA Healthcare by 51.2% in the first quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock valued at $2,543,000 after purchasing an additional 2,584 shares during the last quarter. Empowered Funds LLC increased its stake in HCA Healthcare by 54.3% during the first quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock worth $4,639,000 after acquiring an additional 4,893 shares during the last quarter. Swedbank AB purchased a new position in shares of HCA Healthcare in the first quarter valued at approximately $95,882,000. Finally, EP Wealth Advisors LLC grew its stake in shares of HCA Healthcare by 1.6% during the second quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company’s stock worth $72,335,000 after purchasing an additional 3,516 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.
HCA Healthcare Price Performance
Shares of HCA Healthcare stock opened at $358.57 on Friday. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock has a market capitalization of $92.54 billion, a price-to-earnings ratio of 16.10, a P/E/G ratio of 1.52 and a beta of 1.67. The firm’s 50-day moving average price is $393.62 and its two-hundred day moving average price is $353.85. HCA Healthcare, Inc. has a 1-year low of $223.73 and a 1-year high of $417.14.
HCA Healthcare Announces Dividend
Wall Street Analyst Weigh In
Several research analysts have commented on HCA shares. Morgan Stanley started coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target on the stock. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. KeyCorp reduced their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research report on Monday. Finally, Royal Bank of Canada lifted their target price on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. Five investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have assigned a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $379.11.
Read Our Latest Analysis on HCA Healthcare
Insiders Place Their Bets
In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 1.60% of the company’s stock.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also
- Five stocks we like better than HCA Healthcare
- Insider Trades May Not Tell You What You Think
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Roth IRA Calculator: Calculate Your Potential Returns
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Short Selling: How to Short a Stock
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.